Others may have temporary symptoms such as mild nausea, headache, or mild dizziness
[DOI] [PMC free article] [PubMed] [Google Scholar] 3.Sikiric P., Rucman R., Turkovic B., Sever M., Klicek R., Radic B., Drmic D., Stupnisek M., Misic M., Vuletic L.B., et al
Clinical Gastroenterology and Hepatology
FDA-Approved GLP-1 Medications Heres a list of FDA-approved GLP-1 medications , grouped by purpose: For Type 2 Diabetes : Brand Name Generic Name Approved Byetta Exenatide 2005 Victoza Liraglutide 2010 Trulicity Dulaglutide 2014 Bydureon BCise Exenatide ER 2017 Ozempic Semaglutide 2017 Rybelsus Semaglutide (oral) 2019 Mounjaro Tirzepatide (GLP-1 + GIP) 2022 For Weight Loss / Obesity : Brand Name Generic Name Approved Saxenda Liraglutide 2014 Wegovy Semaglutide 2021 Zepbound Tirzepatide 2023 Whats the Difference Between GLP-1s and GIPs
A physician may need to evaluate persistent vomiting, severe abdominal pain, signs of dehydration, worsening reflux, gallbladder symptoms, low blood sugar risk in patients using diabetes medications, kidney function concerns, unintentional under-eating, rapid weakness or muscle loss, and medication interactions
This raises hope that retatrutide might help patients achieve weight loss on the order of 2530% or more if given for a longer duration a level previously seen only with bariatric surgery